Genexa Raises $60M in Series A Funding


Genexa, an Atlanta, GA-based clean pharmaceutical company, raised $60M in Series A funding.

The round was led by Jared Stein, Co-Founder and Managing Partner of Monogram Capital, with participation from Unilever Ventures, Verlinvest, Northcastle Partners,and Point King Capital, as well as Gwyneth Paltrow, Chris Pratt, Katherine Schwarzenegger, Donald Glover, Lily Aldridge, Jennifer Meyer, Regina Hall, Sanaa Lathan, Don Cheadle, Bridgid Coulter, Lana Parrilla, Patrick Schwarzenegger, Tony Kanal, Zoey Deutch, Brandon Shainfeld and Angela Fletcher.

The company intends to use the funds to expand its development efforts.

Led by  David Johnson and Max Spielberg, Genexa offers OTC medicines spanning all traditional categories of OTC medicine, including pain and fever, cold and flu, and digestion and allergy, with products for infants, kids and adults alike. Its patented preservative system enables the company company to offer products which have the same effective active ingredients as the category leaders but without the unnecessary and potentially harmful fillers found in most other traditional OTC offerings. Their list of unnecessary ingredients that are not found in Genexa formulas include sorbitol, propylene glycol, artificial dyes, synthetic binders, talc and common allergens like gluten and lactose.

All of Genexa’s products are manufactured according to FDA guidelines and are Non-GMO Project Verified and gluten-free. Many are certified organic and vegan as well.

Products are available at over 45,000 retailers nationwide including Walmart, Target, CVS, Kroger, Target, Walgreens, Whole Foods and Sprouts, as well as online at and Amazon.